Med. praxi. 2011;8(12):544-546

Modern Trends in hormonal contraception

MUDr.Martina Novotná
Gynekologicko-porodnické oddělení, Nemocnice Milosrdných bratří, Brno
Unica &ndash, Klinika pro léčbu ženských nemocí a neplodnosti, Brno

The basic task is to help a woman gynecologist for her to find the most effective and safe form of contraception. The article provides

basic instructions on how to approach carefully to minimize the risks associated with hormonal (especially combined) and contraceptive

how to optimize the selection of a particular contraceptive according to user requirements and their potential health problems. It also

includes information about the latest trends in hormonal contraception.

Keywords: safety contraception, contraception tailored, modern forms of contraception

Published: December 15, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotná M. Modern Trends in hormonal contraception. Med. praxi. 2011;8(12):544-546.
Download citation

References

  1. Bitzer J. Contraception in the Consumer Age, Berlin, 2009, přednáška, ESC congress.
  2. Burkman R, Bell C, Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception. 2011; 84(1): 19-34. Go to original source... Go to PubMed...
  3. Doporučené postupy v gynekologii a porodnictví. Moderní gynekologie a porodnictví 2007; 16(1), supplementum.
  4. Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011; 117(3): 705-719. Go to original source... Go to PubMed...
  5. Fait T, Apetauer I. Význam konzultace při výběru kombinované hormonální antikoncepce - výsledky projektu CHOICE (Contraception Health Research Of Informed Choice Experience) v České a Slovenské republice. Ceska Gynekol. 2011; 76(2): 140-144.
  6. Fraser IS, Römer T, Parke S, Zeun S, Mellinger U, Machlitt A, Jensen JT. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, doubleblind Phase III trial. Hum Reprod. 2011 Jul 21. [Epub ahead of print]. Go to original source... Go to PubMed...
  7. Gregorová P, Weiss P, Unzeitig V, Cibula D. Antikoncepční chování českých žen - výsledky národního výzkumu. Ceska Gynekol. 2010; 75(2): 141-148.
  8. Guida M, Di Spiezio Sardo A, Bramante S, Sparice S, Acunzo G, Tommaselli GA, Di Carlo C, Pellicano M, Greco E, Nappi C. Effects of two types of hormonal contraception-oral versus intravaginal-on the sexual life of women and their partners. Hum Reprod. 2005; 20(4): 1100-1106. Go to original source... Go to PubMed...
  9. Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2009; 5(2): CD006586. Review. Go to original source... Go to PubMed...
  10. Milsom I, Lete I, Bjertnaes A, Rokstad K, Lindh I, Gruber CJ, Birkhäuser MH, Aubeny E, Knudsen T, Bastianelli C. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Hum Reprod. 2006; 21(9): 2304-2311. Go to original source... Go to PubMed...
  11. Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception. 2006; 74(3): 220-223. Go to original source... Go to PubMed...
  12. Sitruk-Ware R. Contraception: an international perspective. Contraception. 2006; 73(3): 215-222. Epub 2005 Nov 14. Go to original source... Go to PubMed...
  13. Sitruk-Ware R, Nath A. The use of newer progestins for contraception Contraception. 2010; 82(5): 410-417. Go to original source... Go to PubMed...
  14. WHO Medical Eligibility Criteria 2011.
  15. Yuzpe AA. Oral contraception: trends over time. Reprod Med. 2002; 47(Suppl 11): 967-973.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.